Skip to content

Inogen INGN Other Income (Expense)

Other Income (Expense) at other companies

Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$35K-53.3%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$77K-53.9%
Savara logo
SavaraSVRA
$1.71M-5.0%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$2.75M+9.2%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's other income (expense)?
Inogen (INGN) reported other income (expense) of $838K in Q1 2026.
How has Inogen's other income (expense) changed year-over-year?
Inogen's other income (expense) decreased by 39.5% year-over-year, from $1.39M to $838K.
What is the long-term trend for Inogen's other income (expense)?
Over 4 years (2021 to 2025), Inogen's other income (expense) has grown at a 85.2% compound annual growth rate (CAGR), from -$581K to $6.83M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.